Structural Formula (Polymyxin B For Injection Usp 1)
Polymyxin B Injection, Powder, For Solution
Product Images NDC 0143-9941
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 0143-9941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vial (Polymyxin B For Injection Usp 2)
Shelfpack (Polymyxin B For Injection Usp 3)
This is a label for a medication called Polymyxin B Sulfate, which is contained in a vial with 500,000 units. The drug is administered through intramuscular, intravenous, and intrathecal routes, and the recommended dosage should not exceed 25,000 units per kg per day. This drug can be neurotoxic and nephrotoxic. The product must be stored in a refrigerator between 2°C to 5°C and should be discarded after 72 hours if not used. The manufacturer is Hikma Farmaceutica (Portugal), S.A. The drug is distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922. This medication is for hospital use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
